The Institute for Translational Research and Molecular Imaging was established to conduct multidisciplinary molecular imaging research and validation of therapeutics, providing evidence for the development of new diagnostic and therapeutic methods for rare and intractable diseases. It also aims to facilitate the early clinical introduction of novel therapies, as well as the development of biopharmaceuticals.

• Development of new therapies for rare and intractable diseases
• Development of molecular imaging platforms for biopharmaceutical research and clinical applications
• Other projects related to the above objectives